Positron Emission Tomography-Based Response to Target and Immunotherapies in Oncology.
PERCIST criteria
immunotherapy
positron emission tomography
response assessment
target therapy
Journal
Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208
Informations de publication
Date de publication:
24 Jul 2020
24 Jul 2020
Historique:
received:
15
06
2020
revised:
11
07
2020
accepted:
21
07
2020
entrez:
30
7
2020
pubmed:
30
7
2020
medline:
18
3
2021
Statut:
epublish
Résumé
2-deoxy-2-[
Identifiants
pubmed: 32722205
pii: medicina56080373
doi: 10.3390/medicina56080373
pmc: PMC7466359
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
J Nucl Med. 2017 Dec;58(12):1906-1912
pubmed: 28912144
Lancet Oncol. 2016 Sep;17(9):1283-94
pubmed: 27451390
Clin Cancer Res. 2006 Oct 1;12(19):5659-67
pubmed: 17020967
Blood. 2006 Jan 1;107(1):52-9
pubmed: 16150944
J Nucl Med. 2018 Jan;59(1):66-74
pubmed: 29025982
Abdom Radiol (NY). 2019 Mar;44(3):836-844
pubmed: 30467723
Nucl Med Biol. 2020 Feb 22;:
pubmed: 32229068
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
J Clin Oncol. 2009 Jun 1;27(16):2697-704
pubmed: 19380450
Oncotarget. 2016 May 10;7(19):27848-54
pubmed: 27036043
Eur J Cancer. 1999 Dec;35(13):1773-82
pubmed: 10673991
Cancer. 1981 Jan 1;47(1):207-14
pubmed: 7459811
Eur J Radiol. 2018 Apr;101:65-71
pubmed: 29571803
Lancet. 2010 Apr 24;375(9724):1437-46
pubmed: 20398925
J Immunother Cancer. 2020 Apr;8(1):
pubmed: 32345624
Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):384-391
pubmed: 29124280
Clin Nucl Med. 2020 Mar;45(3):187-194
pubmed: 31977479
Clin Cancer Res. 1996 Jun;2(6):933-9
pubmed: 9816253
Rofo. 2020 Jul;192(7):657-668
pubmed: 32215902
J Clin Oncol. 2007 Aug 20;25(24):3746-52
pubmed: 17646666
Cancer Discov. 2015 Jan;5(1):72-81
pubmed: 25380844
Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1276-83
pubmed: 25808631
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):55-66
pubmed: 28361188
Pigment Cell Melanoma Res. 2016 Sep;29(5):572-7
pubmed: 27333363
J Thorac Dis. 2014 Jun;6(6):677-83
pubmed: 24976990
Future Oncol. 2016 Feb;12(3):333-42
pubmed: 26768648
World J Clin Oncol. 2020 Feb 24;11(2):53-73
pubmed: 32133275
Eur J Nucl Med Mol Imaging. 2020 Apr 15;:
pubmed: 32296882
Immunity. 1994 Aug;1(5):405-13
pubmed: 7882171
Discov Med. 2016 Apr;21(116):305-13
pubmed: 27232516
J Clin Oncol. 2018 Jan 10;36(2):136-143
pubmed: 29220298
J Nucl Med. 2019 Mar;60(3):335-341
pubmed: 30413661
Eur J Radiol. 2016 Jun;85(6):1224-31
pubmed: 27161074
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):238-250
pubmed: 30291373
Cancers (Basel). 2020 Feb 19;12(2):
pubmed: 32092983
J Nucl Med. 2011 Oct;52(10):1541-9
pubmed: 21903739
Oncol Lett. 2016 Aug;12(2):1493-1500
pubmed: 27446459
Lung Cancer. 2008 Feb;59(2):203-10
pubmed: 17913282
Nat Commun. 2018 Nov 7;9(1):4664
pubmed: 30405135
J Nucl Med. 2018 Aug;59(8):1212-1218
pubmed: 29602822
Cancer. 2007 Dec 15;110(12):2614-27
pubmed: 18000991
Eur J Nucl Med Mol Imaging. 2013 May;40(5):800-16
pubmed: 23389427
J Nucl Med. 2009 May;50 Suppl 1:122S-50S
pubmed: 19403881
Front Oncol. 2016 Jul 15;6:152
pubmed: 27471678
Eur J Cancer. 2003 Sep;39(14):2012-20
pubmed: 12957455
J Clin Oncol. 2003 Jul 15;21(14):2651-7
pubmed: 12860940
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1014-1024
pubmed: 28283702
Oncotarget. 2014 Dec 15;5(23):12448-58
pubmed: 25504434
PET Clin. 2020 Jan;15(1):23-34
pubmed: 31735299
J Nucl Med. 2020 Jul;61(7):990-998
pubmed: 31806768
Cancers (Basel). 2020 May 27;12(6):
pubmed: 32471030
Clin Cancer Res. 2011 Jul 15;17(14):4799-805
pubmed: 21750198
Ann Nucl Med. 2010 Jul;24(6):441-6
pubmed: 20390384
J Clin Oncol. 2014 Sep 20;32(27):3048-58
pubmed: 25113771
Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1588-1601
pubmed: 28547177
Curr Oncol. 2019 Feb;26(1):e57-e63
pubmed: 30853810
Q J Nucl Med Mol Imaging. 2019 Mar;63(1):7-18
pubmed: 29521482
Clin Cancer Res. 2009 Dec 1;15(23):7412-20
pubmed: 19934295
Lancet Oncol. 2019 Apr;20(4):546-555
pubmed: 30846327
J Nucl Med. 2011 Nov;52(11):1684-1689
pubmed: 22045706
Eur J Nucl Med Mol Imaging. 2020 Apr 21;:
pubmed: 32338306
J Clin Med. 2020 Mar 07;9(3):
pubmed: 32156047
ESMO Open. 2018 Jan 13;3(1):e000278
pubmed: 29387476
EJNMMI Res. 2018 Aug 15;8(1):80
pubmed: 30112704
Am Soc Clin Oncol Educ Book. 2019 Jan;39:321-330
pubmed: 31099673
Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1859-1868
pubmed: 31214790
Cancer. 1998 Jun 1;82(11):2256-61
pubmed: 9610707
Nat Med. 2018 Dec;24(12):1852-1858
pubmed: 30478423
Q J Nucl Med Mol Imaging. 2015 Dec;59(4):462-8
pubmed: 24695005
J Natl Cancer Inst. 2000 Feb 2;92(3):205-16
pubmed: 10655437
Ann Oncol. 2018 Oct 1;29(10):2115-2120
pubmed: 30137228
Curr Radiopharm. 2016;9(1):6-7
pubmed: 26655262
Nat Rev Cancer. 2012 Mar 22;12(4):252-64
pubmed: 22437870
Rev Recent Clin Trials. 2016;11(4):297-305
pubmed: 27457350
J Nucl Med. 2020 Jun;61(6):821-826
pubmed: 31862803
J Nucl Med. 2017 Sep;58(9):1421-1428
pubmed: 28360208
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):41-54
pubmed: 28396911
Eur J Nucl Med Mol Imaging. 2015 Mar;42(3):386-96
pubmed: 25359635
Nat Rev Clin Oncol. 2015 Jul;12(7):395-407
pubmed: 25917254
Eur J Cancer. 2018 Jun;96:91-104
pubmed: 29698933
Mayo Clin Proc. 2015 Apr;90(4):500-4
pubmed: 25792242
Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):56-66
pubmed: 28828507
Cancers (Basel). 2020 Feb 06;12(2):
pubmed: 32041105
Clin Genitourin Cancer. 2019 Feb;17(1):15-22
pubmed: 30425003
Eur J Cancer. 2018 Mar;91:136-144
pubmed: 29360605
Medicine (Baltimore). 2019 Jul;98(29):e16417
pubmed: 31335691
Curr Drug Metab. 2009 Jun;10(5):470-81
pubmed: 19689244
Lancet Oncol. 2018 Feb;19(2):229-239
pubmed: 29361469
Clin Nucl Med. 2019 Apr;44(4):e272-e279
pubmed: 30688730
Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2301-2312
pubmed: 32206839
EJNMMI Res. 2020 Apr 19;10(1):40
pubmed: 32307594
Int J Cancer. 2015 Jul 15;137(2):262-6
pubmed: 24789362
Acta Med Okayama. 2019 Aug;73(4):341-347
pubmed: 31439957
J Nucl Med. 2010 Sep;51(9):1344-8
pubmed: 20720059